We added 16 PCTs and 26 U.S. patent applications focused on psychedelics to our tracker in the month of April 2024. New entries came from the likes of Psilera, Aya Biosciences, Algernon, ASRI, Terran, GH Research, and more. (Subscribe or sign-in, below, to explore the interactive tables.) *** In early April, a shared PCT (WO2024073356) from psychedelic drug developers the…


Previous articleBreaking Through Bureaucracy: Can D.C. Embrace Evidence-Based Drug Policy?
Next articleThe Economics of Psychedelics